[Thermal treatments in organic vascular occlusion syndromes].
D001161:Arteriosclerosis / Q000150:complications; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006358:Hot Temperature; D006801:Humans; D007455:Iodine / Q000097:blood / Q000627:therapeutic use; D007552:Isotonic Solutions; D007773:Lactates / Q000097:blood; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D026741:Physical Therapy Modalities; D011188:Potassium / Q000097:blood; D011773:Pyruvates / Q000097:blood; D012039:Regional Blood Flow; D012964:Sodium / Q000097:blood; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000628:therapy*; D014978:Xenon
D007552:Isotonic Solutions; D007773:Lactates; D011773:Pyruvates; D014978:Xenon; D007455:Iodine; D012964:Sodium; D003402:Creatine Kinase; D011188:Potassium
Uber thermische Behandlungsformen bei organischen Gefässverschlusssyndromen.